Provided by Tiger Trade Technology Pte. Ltd.

Atrium Therapeutics

8.28
-0.1400-1.66%
Post-market: 8.280.00000.00%16:10 EDT
Volume:197.31K
Turnover:1.64M
Market Cap:141.63M
PE:-2.15
High:8.46
Open:8.38
Low:8.22
Close:8.42
52wk High:16.77
52wk Low:8.05
Shares:17.11M
Float Shares:15.72M
Volume Ratio:0.59
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8578
EPS(LYR):-3.1905
ROE:-43.98%
ROA:-399.25%
PB:0.66
PE(LYR):-2.60

Loading ...

Press Release: Wave Life Sciences Announces GSK's Selection of siRNA Program to Transition to GSK for Further Development

Dow Jones
·
Yesterday

ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor

GlobeNewswire
·
Sep 23

Press Release: Wave Life Sciences Announces Appointment of Dr. Monika Vnuk as Chief Business Officer

Dow Jones
·
Sep 22

Atrium Therapeutics Awards New Hire Options for 13,500 Shares, RSUs for 6,750 Shares Under Inducement Plan

Reuters
·
Sep 22

Atrium Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 22

Alzheimer’s-Fighting ADARx Pharmaceuticals Set for Near $2B IPO

TIPRANKS
·
Sep 21

FMC, AgroSpheres advance bioinsecticide pipeline into field trials

TIPRANKS
·
Sep 17

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 16

ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026

GlobeNewswire
·
Sep 09

GRI Bio Presents New Phase 2a Data at ERS 2026 Defining GRI-0621's Mechanism of Action in IPF Across Nine Mechanistic Pillars

GlobeNewswire
·
Sep 08

Adarx Files for US IPO Backed by OrbiMed and Bain Capital

Stock News
·
Sep 05

Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference

GlobeNewswire
·
Sep 04

Atrium Therapeutics to Present at Wells Fargo Annual Healthcare Conference

Reuters
·
Sep 02

ProQR to Participate in Upcoming Investor Conferences in September 2026

GlobeNewswire
·
Sep 02

Circio boosts circVec gene therapy data and secures funding runway to 2030

TIPRANKS
·
Sep 01

Korro to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Aug 27

Circio bolsters board as it advances circular RNA gene therapy platform

TIPRANKS
·
Aug 26

Press Release: Valerio Therapeutics Announces Signing of Definitive Agreements for the Acquisition of Etherna Immunotherapies, Building a Leading Platform in Targeted RNA, and Eur40.25 Million PIPE Financing from New and Existing Investors

Dow Jones
·
Aug 24

BioNTech’s New HIV RNA Vaccine Trial: What Investors Should Watch Now

TIPRANKS
·
Aug 22

Brii Biosciences Narrows Interim Loss as HBV and RNA Pipelines Advance

TIPRANKS
·
Aug 21